相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma et al.
NATURE IMMUNOLOGY (2021)
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
Shoichi Iriguchi et al.
NATURE COMMUNICATIONS (2021)
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
Antonio Lopez-Beltran et al.
CANCERS (2021)
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
Marsha Pellegrino et al.
CELLS (2021)
The cancer metabolic reprogramming and immune response
Longzheng Xia et al.
MOLECULAR CANCER (2021)
Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication
Haitao Guo et al.
NATURE IMMUNOLOGY (2021)
The complex Integration of T-cell Metabolism and Immunotherapy
Matthew Z. Madden et al.
CANCER DISCOVERY (2021)
Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors
Shih-Wei Chen et al.
STEM CELL REPORTS (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
Seung E. Cha et al.
ONCOIMMUNOLOGY (2021)
Viral vector platforms within the gene therapy landscape
Jote T. Bulcha et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Mesothelin-targeted CAR-T cell therapy for solid tumors
Astero Klampatsa et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Guiding T lymphopoiesis from pluripotent stem cells by defined transcription factors
Rongqun Guo et al.
CELL RESEARCH (2020)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
Developing a simple method to enhance the generation of cone and rod photoreceptors in pluripotent stem cell-derived retinal organoids
Christopher Horton et al.
STEM CELLS (2020)
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells
Tatsuki Ueda et al.
CANCER SCIENCE (2020)
Tumor Immunology and Tumor Evolution: Intertwined Histories
Jerome Galon et al.
IMMUNITY (2020)
A functional variant near XCL1 gene improves breast cancer survival via promoting cancer immunity
Wen-Cheng Chou et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
CAR T cells: continuation in a revolution of immunotherapy
Anurag K Singh et al.
LANCET ONCOLOGY (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
Stephany Y. Tzeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination
Jasper J. P. van Beek et al.
CELL REPORTS (2020)
Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development
Carissa Dege et al.
DEVELOPMENTAL CELL (2020)
Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential
Lucas Lange et al.
STEM CELL REPORTS (2020)
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
Aaron R. Lim et al.
ELIFE (2020)
In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes
Shiwani Agarwal et al.
MOLECULAR THERAPY (2020)
Overexpression of early T cell differentiation-specific transcription factors transforms the terminally differentiated effector T cells into less differentiated state
Hua Lu et al.
CELLULAR IMMUNOLOGY (2020)
Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated Naive-Like Cells Capable of Restricting Mycobacteria Growth
Tatiana Nenasheva et al.
FRONTIERS IN IMMUNOLOGY (2020)
Oncolytic viruses for cancer immunotherapy
Otto Hemminki et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells
Josephine Wesely et al.
CELL REPORTS (2020)
Small Molecule Epigenetic Modulators in Pure Chemical Cell Fate Conversion
Zhao-Di Yuan et al.
STEM CELLS INTERNATIONAL (2020)
Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma
Karin Straathof et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters
Mariela Montano-Samaniego et al.
FRONTIERS IN ONCOLOGY (2020)
Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity
Yingzhong Li et al.
NATURE CANCER (2020)
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder
Mathieu Rouanne et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy
Frank Cichocki et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer
Soyoung A. Oh et al.
NATURE CANCER (2020)
An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial
Julie Charles et al.
ONCOIMMUNOLOGY (2020)
A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells
Frederic Van Gool et al.
IMMUNITY (2019)
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Gene Therapy Leaves a Vicious Cycle
Reena Goswami et al.
FRONTIERS IN ONCOLOGY (2019)
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
Vivek Verma et al.
NATURE IMMUNOLOGY (2019)
Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans
Josephine Juttner et al.
NATURE NEUROSCIENCE (2019)
Induced Pluripotent Stem Cell (iPSC)-Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges
Alexandros Nianias et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Weilei Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III- IV melanoma
Robert H. Andtbacka et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Lanqi Gong et al.
CANCER COMMUNICATIONS (2019)
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Guangchuan Wang et al.
NATURE IMMUNOLOGY (2019)
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain
Devon S. Svoboda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
F. Zhang et al.
NATURE COMMUNICATIONS (2019)
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4
Jianlin Liang et al.
ELIFE (2019)
In vivo generated human CAR T cells eradicate tumor cells
Shiwani Agarwal et al.
ONCOIMMUNOLOGY (2019)
Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis
Dana Ishay-Ronen et al.
CANCER CELL (2019)
Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors
Zhuo Cheng et al.
CELL RESEARCH (2019)
Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells
Amelie Montel-Hagen et al.
CELL STEM CELL (2019)
Plasmacytoid Dendritic Cells: Development, Regulation, and Function
Boris Reizis
IMMUNITY (2019)
Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis
Zhong Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Understanding and Modulating Immunity With Cell Reprogramming
Cristiana F. Pires et al.
FRONTIERS IN IMMUNOLOGY (2019)
Metabolic Regulation of Macrophage Polarization in Cancer
Kamiya Mehla et al.
TRENDS IN CANCER (2019)
Immune checkpoint inhibitors for metastatic bladder cancer
Francesco Massari et al.
CANCER TREATMENT REVIEWS (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo
Nigel G. Kooreman et al.
CELL STEM CELL (2018)
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Jason Chesney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Tumor-derived exosomes antagonize innate antiviral immunity
Liang Gao et al.
NATURE IMMUNOLOGY (2018)
Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes
Mengyun Zhang et al.
NATURE IMMUNOLOGY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Adverse Events Associated with Immune Checkpoint Blockade
Kenar D. Jhaveri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Efficient production of erythroid, megakaryocytic and myeloid cells, using single cell-derived iPSC colony differentiation
Marten Hansen et al.
STEM CELL RESEARCH (2018)
Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution
Shelly M. Williams et al.
TRANSFUSION (2018)
Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
Prajakta Shinde et al.
SCIENTIFIC REPORTS (2018)
Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
Nagako Sougawa et al.
SCIENTIFIC REPORTS (2018)
Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells
Junya Kitadani et al.
SCIENTIFIC REPORTS (2018)
Chimeric antigen receptors that trigger phagocytosis
Meghan A. Morrissey et al.
ELIFE (2018)
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
Patty Sachamitr et al.
FRONTIERS IN IMMUNOLOGY (2018)
In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome
Anett Pfeiffer et al.
EMBO MOLECULAR MEDICINE (2018)
Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
Jie Yuan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas
Kai Yao et al.
NATURE (2018)
In vivo reprogramming of wound-resident cells generates skin epithelial tissue
Masakazu Kurita et al.
NATURE (2018)
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy
Atsutaka Minagawa et al.
CELL STEM CELL (2018)
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
Qing Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
Fabio F. Rosa et al.
SCIENCE IMMUNOLOGY (2018)
Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers
Qiong J. Wang et al.
CLINICAL CANCER RESEARCH (2017)
The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration
Birgit Ritschka et al.
GENES & DEVELOPMENT (2017)
Nonintegrating Gene Therapy Vectors
Takis Athanasopoulos et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
Samra Turajlic et al.
LANCET ONCOLOGY (2017)
Engineering Natural Killer Cells for Cancer Immunotherapy
Katayoun Rezvani et al.
MOLECULAR THERAPY (2017)
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel et al.
NATURE (2017)
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
Tetsuhiro Kikuchi et al.
NATURE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Alexandra-Chloe Villani et al.
SCIENCE (2017)
Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells
Stephanie Sontag et al.
STEM CELLS (2017)
Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+T Cell Clones of Sjogren's Syndrome
Mana Iizuka-Koga et al.
STEM CELL REPORTS (2017)
Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes
Matthias Pawlowski et al.
STEM CELL REPORTS (2017)
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
Mathias Bernhardt et al.
STEM CELL REPORTS (2017)
Directed Differentiation of Human Pluripotent Stem Cells to Microglia
Panagiotis Douvaras et al.
STEM CELL REPORTS (2017)
Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy
Lior Nissim et al.
CELL (2017)
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma
Sara M. Federico et al.
CLINICAL CANCER RESEARCH (2017)
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation
Stefan O. Ciurea et al.
BLOOD (2017)
Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy
Ying Zhang et al.
CANCER CELL (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease
Mark P. Chao et al.
CELL STEM CELL (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
Gerty Schreibelt et al.
CLINICAL CANCER RESEARCH (2016)
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
Sabrina Genssler et al.
ONCOIMMUNOLOGY (2016)
Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis
Guangqi Song et al.
CELL STEM CELL (2016)
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis
Milad Rezvani et al.
CELL STEM CELL (2016)
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
Marie de Charette et al.
EUROPEAN JOURNAL OF CANCER (2016)
Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states
Rajesh Somasundaram et al.
GENES & DEVELOPMENT (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
Annette Romanski et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Efficient derivation of microglia-like cells from human pluripotent stem cells
Julien Muffat et al.
NATURE MEDICINE (2016)
In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells
Hedong Li et al.
NEURON (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Lluc Mosteiro et al.
SCIENCE (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis
Colin L. Sweeney et al.
STEM CELLS (2016)
Making a Hematopoietic Stem Cell
Michael G. Daniel et al.
TRENDS IN CELL BIOLOGY (2016)
Reprogramming bladder cancer cells for studying cancer initiation and progression
Banu Iskender et al.
TUMOR BIOLOGY (2016)
The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal Cord
Lei-Lei Wang et al.
CELL REPORTS (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Loss of tumorigenic potential upon transdifferentiation from keratinocytic into melanocytic lineage
Sabrina Fehrenbach et al.
SCIENTIFIC REPORTS (2016)
C-Myb+ Erythro-Myeloid Progenitor-Derived Fetal Monocytes Give Rise to Adult Tissue-Resident Macrophages
Guillaume Hoeffel et al.
IMMUNITY (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Alfred L. Garfall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages
James Scott McClellan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Direct conversion of human fibroblasts into functional osteoblasts by defined factors
Kenta Yamamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Human Induced Pluripotent Stem Cell-Derived B Lymphocytes Express sIgM and Can Be Generated via a Hemogenic Endothelium Intermediate
Anna French et al.
STEM CELLS AND DEVELOPMENT (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nikolaos Patsoukis et al.
NATURE COMMUNICATIONS (2015)
Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies
Nico Lachmann et al.
STEM CELL REPORTS (2015)
Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes
Tsunao Kishida et al.
STEM CELL REPORTS (2015)
Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells
Yawu Jing et al.
PLOS ONE (2015)
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
Masaru Imamura et al.
BLOOD (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity (vol 26, pg 638, 2014)
Miranda L. Broz et al.
CANCER CELL (2014)
CellNet: Network Biology Applied to Stem Cell Engineering
Patrick Cahan et al.
CELL (2014)
In Vivo Direct Reprogramming of Reactive Glial Cells into Functional Neurons after Brain Injury and in an Alzheimer's Disease Model
Ziyuan Guo et al.
CELL STEM CELL (2014)
Development and Function of Dendritic Cell Subsets
Alexander Mildner et al.
IMMUNITY (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
CSF-1 Receptor Signaling in Myeloid Cells
E. Richard Stanley et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Reprogramming the fate of human glioma cells to impede brain tumor development
Z. Su et al.
CELL DEATH & DISEASE (2014)
In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes
Weida Li et al.
ELIFE (2014)
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Martin Guilliams et al.
NATURE REVIEWS IMMUNOLOGY (2014)
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
Miriam Merad et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits
Yuanchao Xue et al.
CELL (2013)
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
Bruna Corominas-Faja et al.
CELL CYCLE (2013)
Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8+ T Cells
Raul Vizcardo et al.
CELL STEM CELL (2013)
Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
Toshinobu Nishimura et al.
CELL STEM CELL (2013)
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner
Stefan H. Stricker et al.
GENES & DEVELOPMENT (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
Maria Themeli et al.
NATURE BIOTECHNOLOGY (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
X. Zhang et al.
ONCOGENE (2013)
Generation of induced neurons via direct conversion in vivo
Olof Torper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Epigenetic Reprogramming in Cancer
Mario L. Suva et al.
SCIENCE (2013)
C/EBPα Induces Highly Efficient Macrophage Transdifferentiation of B Lymphoma and Leukemia Cell Lines and Impairs Their Tumorigenicity
Francesca Rapino et al.
CELL REPORTS (2013)
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples
Keiki Kumano et al.
BLOOD (2012)
MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
Tilanthi M. Jayawardena et al.
CIRCULATION RESEARCH (2012)
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Kunhua Song et al.
NATURE (2012)
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Li Qian et al.
NATURE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Human induced pluripotent stem cells are capable of B-cell lymphopoiesis
Lee Carpenter et al.
BLOOD (2011)
Dissecting the Oncogenic and Tumorigenic Potential of Differentiated Human Induced Pluripotent Stem Cells and Human Embryonic Stem Cells
Zhumur Ghosh et al.
CANCER RESEARCH (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy
S. Senju et al.
GENE THERAPY (2011)
Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors
Kunihiko Hiramatsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
MicroRNA-mediated conversion of human fibroblasts to neurons
Andrew S. Yoo et al.
NATURE (2011)
Immunogenicity of induced pluripotent stem cells
Tongbiao Zhao et al.
NATURE (2011)
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Pengyu Huang et al.
NATURE (2011)
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
Sayaka Sekiya et al.
NATURE (2011)
Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells
Kitai Kim et al.
NATURE BIOTECHNOLOGY (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
Juliana Idoyaga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Generation of iPSCs from cultured human malignant cells
Jan E. Carette et al.
BLOOD (2010)
Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors
Masaki Ieda et al.
CELL (2010)
Reprogramming of T Cells from Human Peripheral Blood
Yuin-Han Loh et al.
CELL STEM CELL (2010)
Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells
Judith Staerk et al.
CELL STEM CELL (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Defined factors induce reprogramming of gastrointestinal cancer cells
Norikatsu Miyoshi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Reprogramming of T Cells to Natural Killer-Like Cells upon Bcl11b Deletion
Peng Li et al.
SCIENCE (2010)
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Dohoon Kim et al.
CELL STEM CELL (2009)
Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells
Jochen Utikal et al.
JOURNAL OF CELL SCIENCE (2009)
Vaccination with Human Pluripotent Stem Cells Generates a Broad Spectrum of Immunological and Clinical Responses Against Colon Cancer
Yi Li et al.
STEM CELLS (2009)
Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3
Karl R. Karlsson et al.
EXPERIMENTAL HEMATOLOGY (2008)
Reprogramming pancreatic exocrine cells to β-cells
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Trond Aasen et al.
NATURE BIOTECHNOLOGY (2008)
PUA and C/EBPα/β convert fibroblasts into macrophage-like cells
Ru Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Qiao Zhou et al.
NATURE (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors
B Piqueras et al.
BLOOD (2006)
Reprogramming of a melanoma genome by nuclear transplantation
K Hochedlinger et al.
GENES & DEVELOPMENT (2004)
Stepwise reprogramming of B cells into macrophages
HF Xie et al.
CELL (2004)
Cutting edge: Differential chemokine production by myeloid and plasmacytoid dendritic cells
G Penna et al.
JOURNAL OF IMMUNOLOGY (2002)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
